Cintirorgon (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Cintirorgon" in English language version.

Last modified: 09:16:10, 19 August 2026 (UTC)

Ref.Un. Ref.Website

Global rank English rank

66nih.gov

5^th place

55doi.org

2^nd place

doi.org (Global: 2^nd place; English: 2^nd place)

Aicher TD, Van Huis CA, Hurd AR, Skalitzky DJ, Taylor CB, Beleh OM, et al. (September 2021). "Discovery of LYC-55716: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ) Agonist for Use in Treating Cancer". Journal of Medicinal Chemistry. 64 (18): 13410–13428. doi:10.1021/acs.jmedchem.1c00731. PMID 34499493.
Xia L, Tian E, Yu M, Liu C, Shen L, Huang Y, et al. (April 2022). "RORγt agonist enhances anti-PD-1 therapy by promoting monocyte-derived dendritic cells through CXCL10 in cancers". Journal of Experimental & Clinical Cancer Research. 41 (1) 155. doi:10.1186/s13046-022-02289-2. PMC 9034499. PMID 35459193.
Wang H, Zhang G, Zhao C, Xue Y, Zhu D, Chang Y (August 2025). "RORγt agonist LYC-55716 potentiates IFN-α's efficacy in hepatocellular carcinoma through enhancing cytotoxicity of Tc17 cells and infiltration of CD8⁺ T cells". Biochemical Pharmacology. 238 116963. doi:10.1016/j.bcp.2025.116963. PMID 40312017.
Fukuda S, Ikenogami T, Otake K, Miwa S, Maeda K, Yamashita T, et al. (August 2025). "A Concise and Modular Approach to Generate Novel RORγ Agonists". Journal of Medicinal Chemistry. 68 (15) acs.jmedchem.5c00872. doi:10.1021/acs.jmedchem.5c00872. PMID 40677142.
Terawaki T, Suzukawa A, Tanimoto M, Fukuda S, Yamaguchi T (2025). "A Novel RORγ-Selective Agonist Facilitates the Infiltration of Effector T Cells and Innate Immune Cells into Tumor Tissue, Demonstrating Antitumor Efficacy". Biological & Pharmaceutical Bulletin. 48 (12) b25-00540. doi:10.1248/bpb.b25-00540. PMID 41338992.

nih.gov (Global: 5^th place; English: 5^th place)

pubmed.ncbi.nlm.nih.gov

Aicher TD, Van Huis CA, Hurd AR, Skalitzky DJ, Taylor CB, Beleh OM, et al. (September 2021). "Discovery of LYC-55716: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ) Agonist for Use in Treating Cancer". Journal of Medicinal Chemistry. 64 (18): 13410–13428. doi:10.1021/acs.jmedchem.1c00731. PMID 34499493.
Xia L, Tian E, Yu M, Liu C, Shen L, Huang Y, et al. (April 2022). "RORγt agonist enhances anti-PD-1 therapy by promoting monocyte-derived dendritic cells through CXCL10 in cancers". Journal of Experimental & Clinical Cancer Research. 41 (1) 155. doi:10.1186/s13046-022-02289-2. PMC 9034499. PMID 35459193.
Wang H, Zhang G, Zhao C, Xue Y, Zhu D, Chang Y (August 2025). "RORγt agonist LYC-55716 potentiates IFN-α's efficacy in hepatocellular carcinoma through enhancing cytotoxicity of Tc17 cells and infiltration of CD8⁺ T cells". Biochemical Pharmacology. 238 116963. doi:10.1016/j.bcp.2025.116963. PMID 40312017.
Fukuda S, Ikenogami T, Otake K, Miwa S, Maeda K, Yamashita T, et al. (August 2025). "A Concise and Modular Approach to Generate Novel RORγ Agonists". Journal of Medicinal Chemistry. 68 (15) acs.jmedchem.5c00872. doi:10.1021/acs.jmedchem.5c00872. PMID 40677142.
Terawaki T, Suzukawa A, Tanimoto M, Fukuda S, Yamaguchi T (2025). "A Novel RORγ-Selective Agonist Facilitates the Infiltration of Effector T Cells and Innate Immune Cells into Tumor Tissue, Demonstrating Antitumor Efficacy". Biological & Pharmaceutical Bulletin. 48 (12) b25-00540. doi:10.1248/bpb.b25-00540. PMID 41338992.

ncbi.nlm.nih.gov

Xia L, Tian E, Yu M, Liu C, Shen L, Huang Y, et al. (April 2022). "RORγt agonist enhances anti-PD-1 therapy by promoting monocyte-derived dendritic cells through CXCL10 in cancers". Journal of Experimental & Clinical Cancer Research. 41 (1) 155. doi:10.1186/s13046-022-02289-2. PMC 9034499. PMID 35459193.

Cintirorgon (English Wikipedia)

doi.org (Global: 2nd place; English: 2nd place)

nih.gov (Global: 5th place; English: 5th place)

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

doi.org (Global: 2^nd place; English: 2^nd place)

nih.gov (Global: 5^th place; English: 5^th place)